Researchers at Moffitt Cancer Center report encouraging early results from a phase 2 study examining whether immunotherapy ...
A phase 2 trial evaluated the efficacy of nivolumab added to brachytherapy, external beam radiation therapy, and ADT in men with high-risk grade group 5 prostate cancer.
Men diagnosed at screening aged 50 years projected to have 16 percent chance that cancer would not have been detected within 15 years.
A new study suggests that prostate cancer screening could reduce deaths by 13 per cent, as cancer experts in the UK assess ...
A man diagnosed with stage four prostate cancer after having a swollen knee says he does not know how long he has left and is ...
WHEN Kevin Hurley noticed his knee was swollen, he assumed it was just a cycling injury. The 61-year-old said the swelling ...
Prophylactic Interventions to Prevent Severe Skin Toxicities in Patients With Non–Small Cell Lung Cancer Treated With Nivolumab + Ipilimumab With or Without Chemotherapy Black men face the highest ...
Most prostate cancers rely on male sex hormones, known as androgens, to grow. As a result, standard treatment focuses on ...
Prostate cancer is being diagnosed much later than other cancers, The Telegraph can reveal. An investigation has shown that ...
Drs. Pallabi Mustafi and Ruben Raychaudhuri at Fred Hutch Cancer Center recently received Young Investigator Awards from the ...
Prostate cancer, an uncontrolled growth of cells in the prostate, a gland in the male reproductive system located below the bladder, is one of the most common cancers that affects men, especially in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results